Abrahmsen Lars B. 4
4 · Aprea Therapeutics, Inc. · Filed Mar 26, 2020
Insider Transaction Report
Form 4
Abrahmsen Lars B.
SVP, Chief Scientific Officer
Transactions
- Award
Stock Option (right to Buy)
2020-03-24+31,600→ 31,600 totalExercise: $35.50Exp: 2030-03-24→ Common Stock (31,600 underlying)
Footnotes (1)
- [F1]Twenty-five percent of these options vest on March 24, 2021, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.